There were 1,743 press releases posted in the last 24 hours and 359,351 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Milestone Pharmaceuticals Receives Refusal to File Letter from U.S. FDA for New Drug Application for Etripamil in the Treatment of PSVT

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image